American Kratom Association Press Conference In Response to Recent Efforts by the FDA and DEA to Restrict Kratom Access

On November 29th, 2017, The American Kratom Association hosted a press conference in Atlanta, GA. The purpose of the press conference was to rebuke some of the lies and misinformation coming from the FDA’s recent Health Advisory on Kratom and to inform the public of the many benefits kratom has to offer users.

Please watch this video and share it with your friends. Help the AKA combat the anti-kratom propaganda being put out by the Federal Government.

In attendance:

Dave Herman, chair, board of directors, American Kratom Association. Herman is a Georgia native and currently resides in Roswell.

Dr. Jack Henningfield, Ph.D., vice president of Research, Health Policy, and Abuse Liability at PinneyAssociates. Dr. Henningfield previously served as chief of the Clinical Pharmacology Research Branch of the National Institutes of Health’s National Institute on Drug Abuse (NIDA), and is currently an adjunct professor of Behavioral Biology in the Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine. Dr. Henningfield and his PinneyAssociates colleagues conducted a comprehensive review of publicly available data on the same eight factors that the DEA and FDA weigh in deciding to control a substance.

Mac Haddow, legislative director, American Kratom Association.